VIO: ontology classification and study of vaccine responses given various experimental and analytical conditions

Different human responses to the same vaccine were frequently observed. For example, independent studies identified overlapping but different transcriptomic gene expression profiles in Yellow Fever vaccine 17D (YF-17D) immunized human subjects. Different experimental and analysis conditions were likely contributed to the observed differences. To investigate this issue, we developed a Vaccine Investigation Ontology (VIO), and applied VIO to classify the different variables and relations among these variables systematically. We then evaluated whether the ontological VIO modeling and VIO-based statistical analysis would contribute to the enhanced vaccine investigation studies and a better understanding of vaccine response mechanisms. Our VIO modeling identified many variables related to data processing and analysis such as normalization method, cut-off criteria, software settings including software version. The datasets from two previous studies on human responses to YF-17D vaccine, reported by Gaucher et al. (2008) and Querec et al. (2009), were re-analyzed. We first applied the same LIMMA statistical method to re-analyze the Gaucher data set and identified a big difference in terms of significantly differentiated gene lists compared to the original study. The different results were likely due to the LIMMA version and software package differences. Our second study re-analyzed both Gaucher and Querec data sets but with the same data processing and analysis pipeline. Significant differences in differential gene lists were also identified. In both studies, we found that Gene Ontology (GO) enrichment results had more overlapping than the gene lists and enriched pathway lists. The visualization of the identified GO hierarchical structures among the enriched GO terms and their associated ancestor terms using GOfox allowed us to find more associations among enriched but often different GO terms, demonstrating the usage of GO hierarchical relations enhance data analysis. The ontology-based analysis framework supports standardized representation, integration, and analysis of heterogeneous data of host responses to vaccines. Our study also showed that differences in specific variables might explain different results drawn from similar studies.

[1]  L. Visser,et al.  Yellow fever vaccine: past, present and future , 2008, Expert opinion on biological therapy.

[2]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[3]  Roman Jaksik,et al.  Microarray experiments and factors which affect their reliability , 2015, Biology Direct.

[4]  Dragomir R. Radev,et al.  Mining of vaccine-associated IFN-γ gene interaction networks using the Vaccine Ontology , 2011, J. Biomed. Semant..

[5]  J. Curtis,et al.  Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD , 2011, PloS one.

[6]  Yu Lin,et al.  Ontology representation and analysis of vaccine formulation and administration and their effects on vaccine immune responses , 2012, Journal of Biomedical Semantics.

[7]  Yongqun He,et al.  Identification of New Features from Known Bacterial Protective Vaccine Antigens Enhances Rational Vaccine Design , 2017, Front. Immunol..

[8]  Jeffrey A. Wiser,et al.  ImmPort: disseminating data to the public for the future of immunology , 2014, Immunologic Research.

[9]  Christina L Gardner,et al.  Yellow fever: a reemerging threat. , 2010, Clinics in laboratory medicine.

[10]  Bjoern Peters,et al.  VO: Vaccine Ontology , 2009 .

[11]  J. Paul Robinson,et al.  Guidelines for the use of flow cytometry and cell sorting in immunological studies. , 2017, European journal of immunology.

[12]  Jessica A. Turner,et al.  The Ontology for Biomedical Investigations , 2016, PloS one.

[13]  Alfred O. Hero,et al.  The Ontology of Biological and Clinical Statistics (OBCS) for standardized and reproducible statistical analysis , 2016, J. Biomed. Semant..

[14]  Bin Zhao,et al.  Ontobee: A linked ontology data server to support ontology term dereferencing, linkage, query and integration , 2016, Nucleic Acids Res..

[15]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[16]  H. Sieburg,et al.  Stem cell heterogeneity: implications for aging and regenerative medicine. , 2012, Blood.

[17]  Robert Arp,et al.  Building Ontologies with Basic Formal Ontology , 2015 .

[18]  J. Schlom,et al.  Strategies for Cancer Vaccine Development , 2010, Journal of biomedicine & biotechnology.

[19]  Maqc Consortium The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.

[20]  Daniel J. Gaffney,et al.  A survey of best practices for RNA-seq data analysis , 2016, Genome Biology.

[21]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[22]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[23]  Max Theiler,et al.  THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION , 1937, The Journal of experimental medicine.

[24]  Benjamin Haibe-Kains,et al.  Revisiting inconsistency in large pharmacogenomic studies , 2015, bioRxiv.

[25]  Bastian R. Angermann,et al.  Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses , 2008, The Journal of experimental medicine.

[26]  Dimitrios I. Fotiadis,et al.  Machine learning applications in cancer prognosis and prediction , 2014, Computational and structural biotechnology journal.

[27]  W. Langridge,et al.  Autoantigen based vaccines for type 1 diabetes. , 2011, Discovery medicine.

[28]  Ryan R Brinkman,et al.  OntoFox: web-based support for ontology reuse , 2010, BMC Research Notes.

[29]  J. Huggins,et al.  Allergen immunotherapy. , 2004, American family physician.

[30]  Yu Lin,et al.  Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates , 2013, BMC Bioinformatics.

[31]  Huan Li,et al.  The Ontology of Biological and Clinical Statistics (OBCS)-based statistical method standardization and meta-analysis of host responses to yellow fever vaccines , 2017, Quantitative Biology.

[32]  Jack T Stapleton,et al.  Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections. , 2007, Vaccine.

[33]  M. Lynch,et al.  Immunology meets neuroscience – Opportunities for immune intervention in neurodegenerative diseases , 2012, Brain, Behavior, and Immunity.

[34]  Hanlee P. Ji,et al.  The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. , 2006, Nature biotechnology.

[35]  Yu Lin,et al.  The eXtensible ontology development (XOD) principles and tool implementation to support ontology interoperability , 2018, Journal of Biomedical Semantics.

[36]  Bali Pulendran,et al.  Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology , 2009, Nature Reviews Immunology.

[37]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[38]  Eva K. Lee,et al.  Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans , 2009, Nature Immunology.

[39]  M. Ashburner,et al.  The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration , 2007, Nature Biotechnology.

[40]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[41]  Yongqun He,et al.  GOfox: Semantics-based simplified hierarchical classification and interactive visualization to support GO enrichment analysis , 2015, ICBO.

[42]  Kevin C. Dorff,et al.  The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models , 2010, Nature Biotechnology.